Creator Fund’s $56M close in June 2026 targets the wellspring of European deeptech: scientific founders spinning research into companies. It’s early-stage capital aimed at the source of hard technology.

The fund’s thesis

Creator Fund backs technical and scientific founders — often from universities and research labs — at the earliest stages, where capital is scarcest and the science-to-startup gap is widest.

Why this matters for Europe

1. Deeptech starts in the lab. Europe’s strength in research underdelivers in commercialization. Funds focused on scientific founders address the earliest, riskiest gap.
2. Part of a capital-formation wave. Alongside Merantix (€103M) and Pitchdrive (€60M), Creator Fund deepens Europe’s early-stage deeptech ecosystem.
3. A pipeline for the mega-rounds. Today’s seed-stage science companies are the NEURA Robotics and ICEYE of tomorrow.

Practical takeaway (operator + investor)

Scientific and technical founders should know specialist early-stage capital exists for lab-born companies. For LPs, backing science-focused seed funds is a way to access Europe’s deeptech pipeline at the ground floor.

Sources

1. Tech.eu (Creator Fund $56M, investor moves recap): https://tech.eu/2026/06/12/neura-robotics-secures-up-to-1-4b-bending-spoons-files-for-us-ipo-and-uk-pm-unveils-400m-chip-plan/